The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

NCT05005741 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Overweight or Obesity

Interventions

DRUG: Beinaglutide
DRUG: Dulaglutide

Sponsor

Second Xiangya Hospital of Central South University

Collaborators

[object Object]
[object Object]
[object Object]